Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression.

Antitumor peptide FP, fluorescence polarization ITC, isothermal titration calorimetry MDM2 MDM2, murine double minute 2 MDMX MDMX, murine double minute X P53 PMI, P53‒MDM2/MDMX inhibitor SAR, structure‒activity relationship SPR, surface plasmon resonance Systematic mutational analysis

Journal

Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 08 02 2021
revised: 28 05 2021
accepted: 03 06 2021
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 1 10 2021
Statut: ppublish

Résumé

Peptide inhibition of the interactions of the tumor suppressor protein P53 with its negative regulators MDM2 and MDMX activates P53

Identifiants

pubmed: 34589387
doi: 10.1016/j.apsb.2021.06.010
pii: S2211-3835(21)00222-7
pmc: PMC8463443
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2655-2669

Informations de copyright

© 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Références

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3445-54
pubmed: 23946421
FEBS Lett. 1997 Dec 22;420(1):25-7
pubmed: 9450543
Nature. 1992 Jul 2;358(6381):15-6
pubmed: 1614522
Nat Genet. 2001 Sep;29(1):92-5
pubmed: 11528400
Methods Enzymol. 1997;277:366-96
pubmed: 18488318
Science. 1994 Nov 4;266(5186):776-9
pubmed: 7973629
Biopolymers. 2016 Nov;106(6):853-863
pubmed: 27287767
Nat Rev Drug Discov. 2014 Mar;13(3):217-36
pubmed: 24577402
J Med Chem. 2015 Feb 12;58(3):1038-52
pubmed: 25396320
J Am Chem Soc. 2011 Jun 29;133(25):9696-9
pubmed: 21612236
Nat Rev Cancer. 2009 Dec;9(12):862-73
pubmed: 19935675
Chembiochem. 2006 Mar;7(3):515-26
pubmed: 16511824
Nature. 2007 Feb 8;445(7128):661-5
pubmed: 17251932
Nat Rev Cancer. 2009 Oct;9(10):749-58
pubmed: 19776744
J Am Chem Soc. 2007 Mar 7;129(9):2456-7
pubmed: 17284038
J Biol Chem. 1997 Jan 10;272(2):701-4
pubmed: 8995351
J Mol Biol. 2010 Apr 30;398(2):200-13
pubmed: 20226197
Angew Chem Int Ed Engl. 2009;48(46):8712-5
pubmed: 19827079
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14321-6
pubmed: 20660730
J Control Release. 2015 Nov 28;218:29-35
pubmed: 26428461
Curr Opin Chem Biol. 2014 Oct;22:56-61
pubmed: 25282524
Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83
pubmed: 17380161
Bioorg Med Chem. 2009 Mar 1;17(5):2038-46
pubmed: 19211253
Cancer Res. 2007 Sep 15;67(18):8810-7
pubmed: 17875722
Adv Drug Deliv Rev. 2015 Aug 1;90:101-18
pubmed: 25959429
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Science. 2004 Feb 6;303(5659):844-8
pubmed: 14704432
Chem Biol Drug Des. 2013 Jan;81(1):136-47
pubmed: 23253135
Nature. 2009 Nov 12;462(7270):182-8
pubmed: 19907488
Theranostics. 2021 May 3;11(14):6833-6846
pubmed: 34093856
Nature. 1995 Nov 9;378(6553):203-6
pubmed: 7477326
ACS Chem Biol. 2013 Mar 15;8(3):506-12
pubmed: 23214419
J Clin Invest. 2012 Jun;122(6):2018-31
pubmed: 22622039
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17942-7
pubmed: 23071338
J Am Chem Soc. 2012 Apr 18;134(15):6855-64
pubmed: 22444248
J Med Chem. 2012 Jul 12;55(13):6237-41
pubmed: 22694121
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Nature. 1995 Nov 9;378(6553):206-8
pubmed: 7477327
Cell. 1992 Jun 26;69(7):1237-45
pubmed: 1535557
Annu Rev Pharmacol Toxicol. 2009;49:223-41
pubmed: 18834305
Sci Transl Med. 2012 Aug 22;4(148):148ra117
pubmed: 22914623
Science. 1996 Mar 29;271(5257):1854-7
pubmed: 8596952
Chembiochem. 2006 Jan;7(1):29-31
pubmed: 16397877
Curr Pharm Des. 2011;17(6):603-9
pubmed: 21391910
Subcell Biochem. 2014;85:281-319
pubmed: 25201201
Annu Rev Biochem. 2000;69:923-60
pubmed: 10966479
Biochemistry. 1990 Sep 18;29(37):8509-17
pubmed: 2271534
J Biol Chem. 2010 Jan 15;285(3):2174-83
pubmed: 19910468
Angew Chem Int Ed Engl. 2010 May 10;49(21):3649-52
pubmed: 20449836
EMBO J. 1996 Oct 1;15(19):5349-57
pubmed: 8895579
Angew Chem Int Ed Engl. 2004 Apr 13;43(16):2109-12
pubmed: 15083458
Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):180-93
pubmed: 1478777
Nature. 1993 Apr 29;362(6423):857-60
pubmed: 8479525
Science. 2004 Sep 3;305(5689):1466-70
pubmed: 15353804
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3933-8
pubmed: 18316739
J Biol Chem. 2010 Jun 18;285(25):19572-81
pubmed: 20382735
Mol Cancer Res. 2009 Jan;7(1):1-11
pubmed: 19147532
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4665-70
pubmed: 19255450
Adv Funct Mater. 2019 Mar 7;29(10):
pubmed: 32982625
Nat Rev Cancer. 2013 Feb;13(2):83-96
pubmed: 23303139
Chem Rev. 2020 Sep 23;120(18):10079-10144
pubmed: 32794722
J Am Chem Soc. 2010 Mar 10;132(9):2904-6
pubmed: 20158215
Retrovirology. 2011 May 03;8:28
pubmed: 21539734
J Cell Sci. 2007 Feb 1;120(Pt 3):371-8
pubmed: 17251377
J Am Chem Soc. 2012 Jan 11;134(1):103-6
pubmed: 22148351
Chem Sci. 2018 Nov 30;10(5):1522-1530
pubmed: 30809370
Nature. 2007 Feb 8;445(7128):656-60
pubmed: 17251933
Cell. 1999 Oct 1;99(1):103-15
pubmed: 10520998
Cell. 2006 Dec 29;127(7):1323-34
pubmed: 17182091
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Nature. 2000 Nov 16;408(6810):307-10
pubmed: 11099028
Protein Sci. 1995 Nov;4(11):2411-23
pubmed: 8563639
Nature. 2012 Jan 11;481(7382):506-10
pubmed: 22237025
J Am Chem Soc. 2008 Oct 15;130(41):13546-8
pubmed: 18798622
Cancer Cell. 2010 Nov 16;18(5):411-22
pubmed: 21075307

Auteurs

Xiang Li (X)

School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Neelakshi Gohain (N)

Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Si Chen (S)

School of Medicine, Shanghai University, Shanghai 200444, China.

Yinghua Li (Y)

Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.

Xiaoyuan Zhao (X)

Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.

Bo Li (B)

State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.

William D Tolbert (WD)

Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Wangxiao He (W)

Department of Talent Highland, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

Marzena Pazgier (M)

Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Honggang Hu (H)

Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.

Wuyuan Lu (W)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) of School of Basic Medical Sciences and Shanghai Institute of Infectious Disease and Biosecurity of School of Public Health, Fudan University, Shanghai 200032, China.

Classifications MeSH